This course dives into the real-world use of neuromuscular blockers, focusing on when to use which agent, when not to use them, and how to avoid getting burned by their side effects. You’ll review the pharmacokinetics and pharmacodynamics of key agents like succinylcholine, rocuronium, vecuronium, and cisatracurium, including how renal and hepatic failure change your dosing and drug choice. Special emphasis is placed on managing high-risk patients with Myasthenia Gravis and Lambert-Eaton Syndrome, so you can safely tailor neuromuscular blockade to even the most complex neuromuscular pathophysiology.